- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2013 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
From
WORLD
12:00am
Jan 15, 2013
AstraZeneca’s new chief shakes up top team
Reshuffle comes as Soriot tries to reinvigorate pharma group
From
SPECIAL REPORTS
Jan 15, 2013
Misery loves company
Using social media to track outbreaks of disease can provide valuable public health information
Jan 11, 2013
Worst flu outbreak in decade to cost $10bn
Epidemic puts pressure on hospitals and insurers
Jan 10, 2013
FDA examines pain pill formula regulation
Generics may be forced to adopt tamper-resistant technology
Jan 7, 2013
Roche abandons pursuit of Illumina
Swiss pharmaceutical group says acquisition deal is off the table
Jan 7, 2013
Sanofi unit acquires Rolaids from J&J
Antacid to be relaunched following withdrawal from market in 2010
- Comment Sanofi – pick-me-up
- Inside Business France’s bruiser disrupts Sanofi’s recovery
From
FINANCIALS
Jan 4, 2013
Goldman seeks $7m legal costs from Gupta
Further claim likely for $35m advance
From
FINANCIALS
Jan 3, 2013
Ex-SAC official denies insider trading claims
Martoma pleads not guilty over pharmaceutical results leaking
Jan 2, 2013
Johnson & Johnson set to ship TB medicine
US regulator put treatment on fast track for approval
From
WORLD
Jan 2, 2013
Pakistan villagers bury slain aid workers
Five teachers and two health staff killed by Islamist militants
From
WORLD
Jan 1, 2013
NHS urged to improve obesity services
Royal College of Physicians calls for co-ordinated action
Dec 26, 2012
Pharma groups hope for diet drugs binge
European regulators remain sceptical over newer treatments
Dec 20, 2012
Eli Lilly settles bribery charges
SEC alleged drug company funnelled millions to a variety of foreign officials
Editorial
from
COMMENT
Dec 20, 2012
Love your gut bugs
Bacteria could play a role in the fight against obesity
From
LEX
Dec 19, 2012
H Lundbeck – future imperfect
Danish drugmaker discovers perils of giving guidance too far out
Dec 18, 2012
Amgen pleads guilty to illegal drug marketing
Medicare and Medicaid billed for thousands of ineligible claims
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
IN DEPTH
MOST POPULAR IN COMPANIES
-
Head of Practice - Interim Management
The McLean Partnership
-
Global Head of Internal Audit
Millennium & Copthorne Hotels plc
-
Group CFO
Technology
-
IT Enterprise Applications Manager
Construction / Civil Engineering, IT
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Global pharma: check that pulse
Patent cliff has been the industry’s excuse for a decade of underperformance